-
1Academic Journal
Source: Bulletin of the Academy of Sciences of Moldova. Medical Sciences; Vol. 71 No. 3 (2021): Medical Sciences; 254-257 ; Buletinul Academiei de Științe a Moldovei. Științe medicale; Vol. 71 Nr. 3 (2021): Ştiinţe medicale; 254-257 ; Вестник Академии Наук Молдовы. Медицина; Том 71 № 3 (2021): Медицина; 254-257 ; 1857-0011 ; 10.52692/1857-0011.2021.3-71
Subject Terms: идиопатическая легочная гипертензия, силденафил, легочная гемодинамика, hipertensiune pulmonară idiopatică, sildenafil, hemodinamică pulmonară, idiopathic pulmonary hypertension, pulmonary haemodynamics
File Description: application/pdf
Relation: https://bulmed.md/bulmed/article/view/3391/3395; https://bulmed.md/bulmed/article/view/3391
-
2Academic Journal
Authors: Martîniuc, Constantin
Source: Bulletin of the Academy of Sciences of Moldova. Medical Sciences; Vol. 69 No. 1 (2021): Medical Sciences; 120-123 ; Buletinul Academiei de Științe a Moldovei. Științe medicale; Vol. 69 Nr. 1 (2021): Ştiinţe medicale; 120-123 ; Вестник Академии Наук Молдовы. Медицина; Том 69 № 1 (2021): Медицина; 120-123 ; 1857-0011 ; 10.52692/1857-0011.2021.1-69
Subject Terms: идиопатическая легочная гипертензия, корреляция между инвазивными и неинвазивными параметрами, выживаемость пациентов, idiopathic pulmonary hypertension, correlation between invasive and non-invasive indices, hipertensiune pulmonară idiopatică, supravieţuirea pacienţilor, corelaţii între parametrii invazivi şi cei neinvazivi
File Description: application/pdf
Relation: https://bulmed.md/bulmed/article/view/3285/3285; https://bulmed.md/bulmed/article/view/3285
-
3Academic Journal
Authors: V. M. Paramonov, T. V. Martynyuk, Z. H. Dadacheva, N. M. Danilov, V. P. Masenko, I. Ye. Chazova
Source: Евразийский Кардиологический Журнал, Vol 0, Iss 1, Pp 12-20 (2016)
Subject Terms: neurohormonal indicators, 03 medical and health sciences, idiopathic pulmonary hypertension, 0302 clinical medicine, острая фармакологическая проба, нейрогуморальные показатели, RC666-701, идиопатическая лёгочная гипертензия, Diseases of the circulatory (Cardiovascular) system, right heart catheterization, acute pharmacological testing, катетеризация правых отделов сердца, 3. Good health
-
4Academic Journal
Source: Евразийский Кардиологический Журнал, Vol 0, Iss 4, Pp 48-55 (2015)
Subject Terms: ambrisentan, идиопатическая лёгочная гипертензия, endothelin receptor antagonists, 02 engineering and technology, антагонисты рецепторов эндотелина, эндотелин-1, 3. Good health, 03 medical and health sciences, idiopathic pulmonary hypertension, 0302 clinical medicine, RC666-701, endothelin-1, 0202 electrical engineering, electronic engineering, information engineering, Diseases of the circulatory (Cardiovascular) system, амбризентан
-
5Academic Journal
Authors: Z. S. Valieva, Z. H. Dadacheva, T. V. Martynyuk, N. M. Danilov, M. A. Saidova, I. Ye. Chazova
Source: Евразийский Кардиологический Журнал, Vol 0, Iss 4, Pp 40-47 (2015)
Subject Terms: sildenafil, идиопатическая лёгочная гипертензия, ингибитор фосфодиэстеразы типа 5, phosphodiesterase type 5 inhibitor, 01 natural sciences, 3. Good health, силденафил, 03 medical and health sciences, idiopathic pulmonary hypertension, 0302 clinical medicine, RC666-701, лаг-специфическая терапия, Diseases of the circulatory (Cardiovascular) system, 0101 mathematics
-
6Academic Journal
Authors: V. V. Bystrov, O. A. Arkhipova, T. V. Martynyuk, M. A. Saidova, O. V. Stukalova, N. M. Danilov, T. A. Sakhnova, I. Ye. Chazova
Source: Евразийский Кардиологический Журнал, Vol 0, Iss 4, Pp 26-33 (2014)
Subject Terms: bosentan, антагонист рецепторов эндотелина, идиопатическая лёгочная гипертензия, ингибитор фосфодиэстеразы типа 5, sildenafil, комбинированная лаг-специфическая терапия, endothelin receptor antagonists, эндотелин-1, phosphodiesterase type 5 inhibitor, 01 natural sciences, 3. Good health, силденафил, 03 medical and health sciences, idiopathic pulmonary hypertension, 0302 clinical medicine, RC666-701, бозентан, Diseases of the circulatory (Cardiovascular) system, 0101 mathematics
-
7Academic Journal
Authors: T. Martynyuk V., S. Nakonechnikov N., V. Masenko P., I. Chazova E., Т. Мартынюк В., С. Наконечников Н., В. Масенко П., И. Чазова Е.
Source: Rational Pharmacotherapy in Cardiology; Vol 8, No 4 (2012); 500-508 ; Рациональная Фармакотерапия в Кардиологии; Vol 8, No 4 (2012); 500-508 ; 2225-3653 ; 1819-6446 ; 10.20996/1819-6446-2012-8-4
Subject Terms: idiopathic pulmonary hypertension, nitric oxide, cytokines, inflammation, идиопатическая легочная гипертензия, оксид азота, цитокины, воспаление
File Description: application/pdf
Relation: https://www.rpcardio.com/jour/article/view/486/506; National guidelines for the diagnosis and treatment of pulmonary hypertension. Kardiovaskulyarnaya Terapiya i Profilaktika 2007;6 (6) Prilozhenie 2: 1–42. Russian (Национальные рекомендации по диагностике и лечению легочной гипертензии. Кардиоваскулярная терапия и профилактика 2007;6 (6) Приложение 2: 1–42).; Johnson B.D., Beck K.C., Zeballos J., et al. Advances in pulmonary laboratory testing. Chest 1999; 116:1377–1387.; Xu W., Kaneko F.T., Zheng S., et al. Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension. FASEB J 2004 18: 1746–1748.; Rabinovitch M. Molecular pathogenesis of pulmonary arterial hypertension. Clin Invest 2008; 118(7):2372–2379.; Trachsel S., Deby-Dupont G., Maurenbrecher E., et al. Association between inflammatory mediators and response to inhaled nitric oxide in a model of endotoxin-induced lung injury. Crit Care 2008; 12(5): R131.; Channick R.N., Newhart J.W., Johnson F.W., et al. Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension: an ambulatory delivery system and initial clinical tests. Chest 1996;109: 1545–1549.; Parsons S., Celermajer D., Savidis E., et al. The effect of inhaled nitric oxide on 6-minute walk distance in patients with pulmonary hypertension. Chest 1998;114(1 Suppl):70S–72S.; Perez-Penate G., Julia-Serda G., Pulido-Duque J.M., et al. One-year continuous inhaled nitric oxide for primary pulmonary hypertension. Chest 2001;119:970–973.; Nakonechnikov S.N., Zykov K.A., Martynyuk T.V. et al. Profile and other inflammatory markers in patients with various forms of pulmonary hypertension. Sistemnye Gipertenzii 2010; (3):61–67. Russian (Наконечников С.Н., Зыков К.А., Мартынюк Т.В. и др. Профиль провоспалительных марке-ров у пациентов с различными формами легочной гипертензии. Системные Гипертензии 2010; (3):61–67).; Hassoun P.M., Mouthon L., Barberà J.A. Inflammation, Growth Factors, and Pulmonary Vascular Re-modeling. J Am Coll Cardiol 2009;54:S10–19.; Dorfmuller P., Perros F., Balabanian K., Humbert M. Inflammation in pulmonary arterial hypertension. Eur Respir J 2003;22:358–363.; Crosswhite P., Sun Z. Nitric Oxide, Oxidative Stress and Inflammation in Pulmonary Arterial Hypertension. J Hypertens 2010; 28(2): 201–212.; Dias-Junior C.A., Cau S.B., Tanus-Santos J.E. Role of nitric oxide in the control of the pulmonary circulation: physiological, pathophysiological, and therapeutic implications. J Bras Pneumol 2008;34:412– 419.; Stevens T., Janssen P.L., Tucker A.D. Acute and long-term TNF-alpha administration increases pulmonary vascular reactivity in isolated rat lungs. J Appl Physiol 1992; 73:708–712.; Beck K.F., Eberhardt, W., Frank S., et al. Inducible NO synthase: role in cellular signalling. J Exper Biology 1999; 202: 645–653.; Takahashi M., Ikeda U., Masuyama J., et al. Nitric oxide attenuates adhesion molecule expression in human endothelial cells. Cytokine 1996;8:817–821.; https://www.rpcardio.com/jour/article/view/486
-
8Academic Journal
Authors: E. A. Mershina, V. E. Sinitsyn, Е. А. Мершина, В. Е. Синицын
Source: Aterotromboz = Atherothrombosis; № 1 (2016); 16-25 ; Атеротромбоз; № 1 (2016); 16-25 ; 2658-5952 ; 2307-1109 ; 10.21518/2307-1109-2016-1
Subject Terms: тромбэндартерэктомия из легочной артерии, idiopathic pulmonary hypertension, chronic thromboembolic pulmonary hypertension, angiopulmonography, dualenergy computed tomography, perfusion defects, pulmonary thromboendarterectomy, идиопатическая легочная гипертензия, хроническая тромбоэмболическая легочная гипертензия, ангиопульмонография, двухэнергетическая компьютерная томография, дефекты перфузии
File Description: application/pdf
Relation: https://www.aterotromboz.ru/jour/article/view/77/123; Чазова И.Е. Первичная легочная гипертензия. Диагностика и лечение. Сердечная недостаточность, 2002, 3(3): 138-143.; Rosenkranz S, Ghofrani HA, Grunig E, Hoeper MM et al. Updated recommendations of the Cologne Consensus Conference on pulmonary hypertension. International Journal of Cardiology, 2011, 152: 1-–60.; Коробкова И.З., Лазуткина В.К. Традиционное рентгенологическое исследование в диагностике сердечно-сосудистых заболеваний. В кн.: Руководство по кардиологии в 4-х тт. / под ред. Чазова Е.И. М.: Практика, 2014: 407-480.; Дземешкевич С.Л., Синицын В.Е., Королев С.В., Мершина Е.А. и др. Септальные дефекты у взрослых: современная диагностика и лечебная тактика. Грудная и сердечно-сосудистая хирургия, 2001, 2: 40-45.; Jenkins D, Mayer E, Screaton N, Madani M. State-ofthe-art chronic thromboembolic pulmonary hypertension diagnosis and management. Eur. Respir. Rev., 2012, 21(123): 32-39.; Klok FA, van Kralingen KW, van Dijk AP et al. Prospective cardiopulmonary screening program to detect chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism. Haematologica, 2010, 95: 970-975.; Surie S, Gibson NS, Gerdes VE et al. Active search for chronic thromboembolic pulmonary hypertension does not appear indicated after acute pulmonary embolism. Thromb. Res., 2010, 125: 202-205.; Dentali F, Donadini M, Gianni M et al. Incidence of chronic pulmonary hypertension in patients with previous pulmonary embolism. Thromb. Res., 2009, 124 (3): 256-258.; Lang IM. Chronic thromboembolic pulmonary hypertension-not so rare after all. N Engl J Med, 2004, 350: 2236-2238.; Шостак Н.А., Клименко А.А., Демидова Н.А., Новиков И.В. Патогенетические механизмы и принципы лечения хронической тромбоэмболической легочной гипертензии. Рациональная фармакотерапия в кардиологии, 2011, 2: 199-203.; Berger G, Azzam ZS, Hardak E, Tavor Y, Yigla M. Idiopathic pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension: can we be certain? Isr Med Assoc J, 2011, 13(2): 106110.; Peacock A, Simonneau G, Rubin L. Controversies, uncertainties and future research on the treatment of chronic thromboembolic pulmonary hypertension. Proc. Am. Thorac. Soc., 2006, 3: 608-614.; Auger WR, Kim NH, Trow TK. Chronic thromboembolic pulmonary hypertension. Clin Chest Med, 2010, 31: 741-758.; Mehta S, Helmersen D, Provencher S et al. Diagnostic evaluation and management of chronic thromboembolic pulmonary hypertension: a clinical practice guideline. Can. Respir. J., 2010, 17(6): 301-334.; Ley S, Ley-Zaporozhan J, Pitton MB et al. Diagnostic performance of state-of-the-art imaging techniques for morphological assessment of vascular abnormalities in patients with chronic thromboembolic pulmonary hypertension (CTEPH). Eur. Radiol., 2012, 22: 607-616.; Reichelt A, Hoeper MM, Galanski M et al. Chronic thromboembolic pulmonary hypertension: evaluation with 64-detector row CT versus digital subtraction angiography. Eur. J. Radiol., 2009, 71: 49-54.; Яблонский П.К., Павлушков Е.В., Федорова Т.А., Головин В.Н. Хроническая тромбоэмболическая легочная гипертензия. Новые Санкт-Петербургские врачебные ведомости, 2009, 2(48): 52-59.; Kreitner K-F, Ley S, Kauczor H-U, Kalden P et al. Assessment of chronic thromboembolic pulmonary hypertension by three-dimensional contrastenhanced MR angiography: comparison with selective intraarterial DSA. Rofo, 2000, 172: 1-6.; Lotz J, Meier C, Leppert A, Galanski M. Cardiovascular flow measurement with phase-contrast MR imaging: basic facts and implementation. Radiographics, 2002, 22: 651-671.; Castaner E, Gallardo X, Ballesterors E et al. CT diagnosis of chronic pulmonary thromboembolism. Radiographics, 2009, 29: 31-53.; Remy-Jardin M, Duhamel A, Deken V, Bouaziz N et al. Systemic collateral supply in patients with chronic thromboembolic and primary pulmonary hypertension: assessment with multidetector row helical CT angiography. Radiology, 2005, 235: 274-281.; Kaplinsky EJ, Favaloro RR, Pombo G et al. Primary pulmonary artery sarcoma resembling chronic thromboembolic pulmonary disease Eur. Respir. J., 2000, 16: 1202-1204.; Nakazawa T, Watanabe Y, Hori Y et al. Lung perfused blood volume images with dual-energy computed tomography for chronic thromboembolic pulmonary hypertension: correlation to scintigraphy with singlephoton emission computed tomography. J. Comput. Assist. Tomogr., 2011, 35(5): 590-595.; Hoey ET, Mirsadraee S, Pepke-Zaba J et al. Dual-energy CT angiography for assessment of regional pulmonary perfusion in patients with chronic thromboembolic pulmonary hypertension: initial experience. Am. J. Roentgenol. 2011, 196(3): 524-532.; Мершина Е.А., Синицын В.Е., Плотникова М.Л. и соавт. Применение двухэнергетической компьютерно-ангиопульмонографии у пациентов с хронической тромбоэмболической легочной гипертензией до и после тромбэндартерэктомии из легочной артерии. Вестник рентгенологии и радиологии, 2013, 2(13): 27-31.; Mayer E. Surgical and post-operative treatment of chronic thromboembolic pulmonary hypertension. Eur Respir Rev, 2010, 19(115): 64-67.; Bonderman D, Skoro-Sajer N, Jakowitsch J, Adlbrecht C et al. Predictors of Outcome in Chronic Thromboembolic Pulmonary Hypertension. Circulation, 2007, 115: 2153-2158.; Mayer E, Jenkins D, Lindner J et al. Surgical management and outcome of patients with CTEPH: results from an international prospective registry. J. of Cardiothoracic Surg, 2011, 141(3): 702-710.; https://www.aterotromboz.ru/jour/article/view/77
-
9Academic Journal
Source: Евразийский Кардиологический Журнал, Vol 0, Iss 2, Pp 58-67 (2016)
Subject Terms: идиопатическая легочная гипертензия, острая фармакологическая проба, микроциркуляция, лазерная допплеровская флоуметрия, idiopathic pulmonary arterial hypertension, acute pharmacological test, microcirculation, laser doppler flowmetry, Diseases of the circulatory (Cardiovascular) system, RC666-701
Relation: https://www.heartj.asia/jour/article/view/5676; https://doaj.org/toc/2225-1685; https://doaj.org/toc/2305-0748; https://doaj.org/article/5532a660e0924498a783129045e52912
-
10Academic Journal
Authors: T. V. Martynyuk, S. N. Nakonechnikov, V. P. Masenko, I. E. Chazova
Source: Рациональная фармакотерапия в кардиологии, Vol 8, Iss 4, Pp 500-508 (2015)
Subject Terms: идиопатическая легочная гипертензия, оксид азота, цитокины, воспаление, Therapeutics. Pharmacology, RM1-950, Diseases of the circulatory (Cardiovascular) system, RC666-701
Relation: http://www.rpcardio.ru/jour/article/view/486; https://doaj.org/toc/1819-6446; https://doaj.org/toc/2225-3653; https://doaj.org/article/77455355be7b4b1f99fa7ee8161df794
-
11Academic Journal
Subject Terms: ИДИОПАТИЧЕСКАЯ ЛЕГОЧНАЯ ГИПЕРТЕНЗИЯ, ОКСИД АЗОТА, ЦИТОКИНЫ, ВОСПАЛЕНИЕ
File Description: text/html
-
12Academic Journal
Authors: Мадеева, Д., Драпкина, О., Схиртладзе, М., Сергеев, И., Ивашкин, В.
Subject Terms: ЛЕГОЧНАЯ ГИПЕРТЕНЗИЯ, СИСТОЛИЧЕСКОЕ ДАВЛЕНИЕ В ЛЕГОЧНОЙ АРТЕРИИ, ИДИОПАТИЧЕСКАЯ ЛЕГОЧНАЯ ГИПЕРТЕНЗИЯ
File Description: text/html
